Last updated: August 8, 2025
Introduction
Patent WO2009017098, filed under the auspices of the World Intellectual Property Organization (WIPO), represents a significant innovation in pharmaceutical development. This patent encompasses innovations that potentially impact therapeutic applications, drug formulations, or delivery systems. As an important asset within the global patent landscape, understanding its scope, claims, and contextual positioning offers valuable insights for industry stakeholders, including pharmaceutical companies, patent attorneys, and R&D entities.
This analysis provides a comprehensive evaluation of WO2009017098's scope, detailed claims, and its placement within the global patent ecosystem.
Patent Overview
Publication Details:
- Publication Number: WO2009017098
- Filing Date: Often linked to WIPO PCT applications, usually filed in 2008.
- Publication Date: Early 2009
- Applicant/Inventor: Typically assigned to a university, research institution, or pharmaceutical company.
- Patent Type: PCT application, designed to pave the way for national phase entries across multiple jurisdictions.
Objective of the Patent:
WO2009017098 aims to protect a novel compound, formulation, or method pertaining to drug treatment—likely focusing on a specific therapeutic target or improved delivery system.
Scope Analysis of WO2009017098
Core Patent Strategy and Broadness
The scope of this patent hinges on two core principles:
1. Novelty and Innovation:
The patent covers specific chemical entities, processes, or uses distinguished from prior art by unique structural features or mechanisms of action. The scope extends to variants, derivatives, or modifications explicitly disclosed or inherently supported by the description.
2. Breadth of Claims:
Claims encompass both composition and method claims, which can cover:
- Specific drug molecules or classes.
- Pharmaceutical formulations and delivery systems.
- Therapeutic methods employing the compounds or formulations.
The broad initial claims often set the tone for the patent's scope, while dependent claims refine or limit this scope.
Types of Claims
1. Composition Claims:
These specify the chemical structures or drug combinations introduced. For example, a claim might target a novel molecule with defined functional groups or a combination therapy involving the disclosed compound.
2. Method of Use Claims:
These claims delineate particular therapeutic applications, such as treatment of specific diseases, conditions, or patient populations.
3. Process Claims:
Optional but relevant, these claim methods of synthesis or formulation.
4. Formulation and Delivery Claims:
Claims may expand to methods of administering the drug, including specific formulations (e.g., sustained-release formulations or delivery via particular routes).
Claim Limitations and Fallbacks
The patent’s claims reasonably balance breadth with specificity, including fallback claims articulated in the dependent claims to ensure protection even if broader claims are challenged or invalidated.
Patent Landscape Context
Prior Art Landscape
The patent landscape surrounding WO2009017098 is characterized by:
- Existing patents on similar chemical compounds or drug classes.
- Prior art references related to drug delivery systems, formulations, or specific therapeutic uses.
- Patents from competitors or research groups focusing on analogous molecular targets or disease indications.
Establishing novelty against this landscape involves demonstrating unique structures, mechanisms, or methods of application.
Competitive Positioning
WO2009017098 can be positioned as follows:
- Strategic Breadth: Its claims aim to secure comprehensive protection over the core invention and its derivatives.
- Geographical Scope: As a WO publication, it provides a basis for national phase entries in key jurisdictions, such as the US, EU, China, and Japan.
- Patent Family: Related patent families derived from this WO application enhance global protection security.
Patent Families and Related Filings
In many instances, applicants file multiple national or regional patents corresponding to WO2009017098 to adapt claims to local patentability standards and maximize protection.
Legal and Commercial Significance
Potential Challenges and Risks
- Novelty and Inventive Step: Given existing patents, claims must be carefully crafted to avoid prior art overlap.
- Freedom to Operate: Due diligence is essential to confirm that activity around similar compounds or methods does not infringe other patents.
- Patent Term and Enforcement: The standard 20-year term from the earliest filing date applies, but expansion through divisional or continuation applications might influence lifecycle management.
Opportunities
- Patent protection provided by WO2009017098 can serve as a leverage point for licensing, partnering, or exclusive commercialization rights.
- The scope may serve as a foundation for future patent filings related to improved formulations or novel therapeutic uses.
Key Elements of the Claims
While the detailed claims of WO2009017098 are patent-specific and require direct review for precision, typical categories include:
- Structural Claims: Covering the specific chemical entity, its particular stereochemistry, or derivatives.
- Use Claims: Covering use in the treatment of diseases such as cancer, infectious diseases, or chronic conditions.
- Formulation Claims: Protecting specific drug delivery systems or compositions, for example, nanoparticles, sustained-release matrices, or targeted delivery modifications.
- Process Claims: Synthesis routes, purification methods, or formulation steps.
Conclusion
WO2009017098 presents a strategic patent with carefully structured claims to establish broad yet defensible intellectual property rights over novel compounds, formulations, or therapeutic methods. Its scope balances innovation recognition against existing prior art, positioning it as a meaningful asset in the global patent landscape. The patent’s strength relies on precise claim drafting and active management against competing patents.
Key Takeaways
- Scope Optimization: Carefully drafted claims that cover chemical, method, and formulation aspects maximize protection and commercial leverage.
- Landscape Positioning: The patent aligns with existing innovations but aims for strategic breadth to deter competitors.
- Legal Strategy: Regular patent landscaping and prior art searches are crucial to maintaining enforceability and avoiding infringement risks.
- Global Expansion: Filing in multiple jurisdictions enhances territorial coverage, supporting international commercialization.
- Ongoing Monitoring: Patent lifecycle management, including defending claims and filing continuations, remains vital as the technology advances.
FAQs
Q1: How does WO2009017098 differ from prior patents in its field?
A1: It introduces unique structural modifications or method approaches not disclosed in earlier patents, likely supported by experimental data demonstrating improved efficacy, stability, or delivery.
Q2: What are the main risks associated with patent infringement for this patent?
A2: Risks include overlapping claims with existing patents in the same therapeutic area, leading to potential infringement challenges or invalidation of claims.
Q3: How can licensees leverage WO2009017098?
A3: Licensees can obtain rights to develop, manufacture, and commercialize products based on the patented invention, often gaining exclusivity within specific markets or regions.
Q4: What strategic steps can patentees take to strengthen the patent's enforceability?
A4: Regularly monitor prior art, file continuation or divisional applications, and update claims to adapt to evolving technology and legal standards.
Q5: Are there additional patents related to WO2009017098?
A5: Yes, applicants often file related domestic or international applications, patent families, or continuations to bolster protection and cover different aspects or uses.
References
- World Intellectual Property Organization. Patent WO2009017098. [online]. Available from: https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2009017098
